semaglutide and prilosec January 2026: New or Expanded Approvals for: GLP-1 Weight Loss, Birth Control Implant, Lung Disease, Menkes, Gaucher; Omeprazole Research Case Studies; Rx-OTC Switches; Medication Tips What Not to Take With
Description
Additionally, both medications can affect electrolyte balance and glucose metabolism, though through different mechanisms
10.1002/14651858.CD011296.pub2 [EL 1
[DOI] [PubMed] [Google Scholar] 88.Bliddal H, et al
Retatrutide is an investigational drug still in clinical trials and is not yet FDA-approved or available
This suggests that CKD represents a particularly modifiable risk factor, and early intervention with semaglutide may be highly effective in preventing secondary CV events in this group [57, 58]
